Neovascular Glaucoma Study
Use of Intravitreal Aflibercept for Neovascular Glaucoma - Malik Kahook, MD.
Eye Pressure Measurement Study
Tolerability and Functionality of a Wireless 24 Hour Ocular Telemetry Sensor in African-American Glaucoma Patients - Leonard Seibold, MD.
Occlusion Prevention for Trabeculectomy Procedures Using Combination Ranibizumab and Mitomycin C (MMC) During Surgery (OCTOPUS STUDY) - Malik Y Kahook, MD.
Effect of Topical Steroid Drops on Blood Glucose
Effects and comparison of commonly used regimen of Prednisolone acetate 1% ophthalmic drops on blood glucose levels in non-diabetic and diabetic subjects - Mina Pantcheva, MD.
Glaucoma and cataract surgery (Glaukos)
Post-approval study of the Glaukos iStent Trabecular Micro-bypass Stent System in conjunction with cataract surgery - Leonard Seibold, MD.
Radiation & Choroidal Melanoma
A prospective pilot study of surgical radiation shielding with vitrectomy and silicone oil tamponade, for the prevention of radiation-induced ocular injury in the treatment of choroidal melanoma with radioactive Iodine-125 plaque brachytherapy - Scott Oliver, MD.
Wet Macular Degeneration (Ophthotech)
Intravitreous administration of Fovista (anti PDGF-B) administered in combination with Lucentis compared to Lucentis monotherapy in patients with subfoveal neovascular age-related macular degeneration - Naresh Mandava, MD.
Tears and Eyelid Surgery Study
Changes in Tear Film Osmolarity After Eyelid Surgery - Eric Hink, MD.
Thyroid Eye Disease (RiverVision)
Placebo-controlled study of an insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody administered every 3 weeks by intravenous infusion in patients suffering from active thyroid eye disease - Eric Hink, MD.
Acute Optic Neuritis
Neuroprotection with ACTH for acute optic neuritis with onset of symptoms within 12 days of current episode - Jeffrey Bennett, MD, PhD. Study coordinator: Ruth Johnson 303-724-7885
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Assess safety and tolerability of investigational product QPI-1007 via intravitreal injections and determine effect on visual functioning in subjects with recent onset (within 14 days) of NAION - Jeffrey Bennett, MD, PhD. Study coordinator: Ruth Johnson 303-724-7885. ClinicalTrials.gov Identifier: NCT02341560.